These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8977319)

  • 21. Constitutive endocytosis and degradation of CD22 by human B cells.
    Shan D; Press OW
    J Immunol; 1995 May; 154(9):4466-75. PubMed ID: 7722303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice.
    Samardzic T; Gerlach J; Muller K; Marinkovic D; Hess J; Nitschke L; Wirth T
    Eur J Immunol; 2002 Sep; 32(9):2481-9. PubMed ID: 12207332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphotyrosine-dependent association between CD22 and protein tyrosine phosphatase 1C.
    Campbell MA; Klinman NR
    Eur J Immunol; 1995 Jun; 25(6):1573-9. PubMed ID: 7542197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD22.
    Engel P
    J Biol Regul Homeost Agents; 2000; 14(4):295-8. PubMed ID: 11215824
    [No Abstract]   [Full Text] [Related]  

  • 25. Intracellular CD22 rapidly moves to the cell surface in a tyrosine kinase-dependent manner following antigen receptor stimulation.
    Sherbina NV; Linsley PS; Myrdal S; Grosmaire LS; Ledbetter JA; Schieven GL
    J Immunol; 1996 Nov; 157(10):4390-8. PubMed ID: 8906814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulated expression of the Cd22 gene as a result of a short interspersed nucleotide element insertion in Cd22a lupus-prone mice.
    Mary C; Laporte C; Parzy D; Santiago ML; Stefani F; Lajaunias F; Parkhouse RM; O'Keefe TL; Neuberger MS; Izui S; Reininger L
    J Immunol; 2000 Sep; 165(6):2987-96. PubMed ID: 10975807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the human complement receptor 2 (CR2, CD21) promoter reveals sequences shared with regulatory regions of other developmentally restricted B cell proteins.
    Rayhel EJ; Dehoff MH; Holers VM
    J Immunol; 1991 Mar; 146(6):2021-6. PubMed ID: 1706386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure and domain organization of the CD19 antigen of human, mouse, and guinea pig B lymphocytes. Conservation of the extensive cytoplasmic domain.
    Zhou LJ; Ord DC; Hughes AL; Tedder TF
    J Immunol; 1991 Aug; 147(4):1424-32. PubMed ID: 1714482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization, tissue expression, and mapping of a novel Siglec-like gene (SLG2) with three splice variants.
    Yousef GM; Ordon MH; Foussias G; Diamandis EP
    Biochem Biophys Res Commun; 2001 Jun; 284(4):900-10. PubMed ID: 11409878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells.
    Berland R; Wortis HH
    J Immunol; 1998 Jul; 161(1):277-85. PubMed ID: 9647234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms regulating CD19, CD20 and CD22 gene expression.
    Kehrl JH; Riva A; Wilson GL; Thévenin C
    Immunol Today; 1994 Sep; 15(9):432-6. PubMed ID: 7524520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of lymphocyte activation by the cell-surface molecule CD22.
    Law CL; Sidorenko SP; Clark EA
    Immunol Today; 1994 Sep; 15(9):442-9. PubMed ID: 7945784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of the murine homologue of CD22, a B lymphocyte-restricted adhesion molecule.
    Torres RM; Law CL; Santos-Argumedo L; Kirkham PA; Grabstein K; Parkhouse RM; Clark EA
    J Immunol; 1992 Oct; 149(8):2641-9. PubMed ID: 1401903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic structure and transcriptional regulation of the early B cell gene chB1.
    Goitsuka R; Mamada H; Kitamura D; Cooper MD; Chen CL
    J Immunol; 2001 Aug; 167(3):1454-60. PubMed ID: 11466365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. cDNA cloning of the B cell membrane protein CD22: a mediator of B-B cell interactions.
    Wilson GL; Fox CH; Fauci AS; Kehrl JH
    J Exp Med; 1991 Jan; 173(1):137-46. PubMed ID: 1985119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD22 associates with the human surface IgM-B-cell antigen receptor complex.
    Leprince C; Draves KE; Geahlen RL; Ledbetter JA; Clark EA
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3236-40. PubMed ID: 8475064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of CD22 (Lyb8) on murine B cells.
    Erickson LD; Tygrett LT; Bhatia SK; Grabstein KH; Waldschmidt TJ
    Int Immunol; 1996 Jul; 8(7):1121-9. PubMed ID: 8757957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difference in CD22 molecules in human B cells and basophils.
    Toba K; Hanawa H; Fuse I; Sakaue M; Watanabe K; Uesugi Y; Higuchi W; Takahashi M; Aizawa Y
    Exp Hematol; 2002 Mar; 30(3):205-11. PubMed ID: 11882357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling.
    Sato S; Jansen PJ; Tedder TF
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13158-62. PubMed ID: 9371816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severely impaired B lymphocyte proliferation, survival, and induction of the c-Myc:Cullin 1 ubiquitin ligase pathway resulting from CD22 deficiency on the C57BL/6 genetic background.
    Poe JC; Haas KM; Uchida J; Lee Y; Fujimoto M; Tedder TF
    J Immunol; 2004 Feb; 172(4):2100-10. PubMed ID: 14764675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.